Bacteriostatic Water: The Reconstitution Reference
Bacteriostatic water is water containing a preservative, commonly 0.9% benzyl alcohol. It is an option when both the peptide and the experiment are compatible with that additive; it is not the only valid solvent for repeated laboratory work.
Three separate checks matter: solvent compatibility, microbial handling and peptide chemical stability. A preservative or a multidose-vial convention does not establish that a reconstituted peptide retains its identity or quantity for 28 days. This reference also explains the stock-concentration calculation.
What bacteriostatic water actually is
A labelled Bacteriostatic Water for Injection product contains sterile water with a stated benzyl-alcohol concentration, often 0.9%. Read the actual product label: formulation, packaging, expiry and authorized use matter.
Bacteriostatic means growth-inhibiting, not a method for sterilizing contaminated material. CDC notes that preservatives do not provide complete protection against bacteria and do not protect against viruses. A preservative never replaces appropriate aseptic handling or makes a contaminated stock acceptable.
Bacteriostatic vs sterile water vs saline
| Solvent | What to check |
|---|---|
| Preserved water | Benzyl-alcohol concentration and compatibility with the peptide/assay |
| Unpreserved water | Solubility and an appropriate laboratory handling/aliquoting procedure |
| 0.9% sodium chloride | Ionic strength/tonicity and whether the particular product contains a preservative |
| Other validated solvent/buffer | Sequence-specific solubility, pH and assay controls |
Unpreserved stocks can be prepared and handled under suitable laboratory protocols; multiple use does not universally require adding benzyl alcohol. Water is not suitable for every hydrophobic sequence. The protocol and actual material specification determine the choice.
Why benzyl alcohol is the deciding variable
Benzyl alcohol can affect the experiment and is not an inert assumption. Include a compatible vehicle control when the assay is sensitive to the additive, and use the solvent specified for the material.
The official injectable-water label carries particular warnings, including neonatal benzyl-alcohol toxicity. That is clinical product information, not a reason to use a research solvent in people. It also does not establish peptide stability or quantify what fraction of sequences will be affected.
Working out the volume for a target concentration
Stock concentration = verified target-peptide amount / final solution volume.
If a vial contains a quantitatively verified 10 mg of target peptide, preparation to 2.00 mL final volume gives 5 mg/mL; preparation to 1.00 mL gives 10 mg/mL. A verified 5 mg amount at a 2.5 mg/mL target requires 2.00 mL final volume. The distinction is final volume, not necessarily the volume of solvent added.
If “10 mg” means gross powder or only a label claim, the actual peptide concentration has not been established. HPLC area purity alone cannot convert gross mass into target amount. See what 99% HPLC means.
Check solubility, vial capacity, measurement accuracy and the model’s required concentration before preparing stock. Record the amount, volume, solvent, lot and preparation date.
Reconstitution technique
1. Confirm sequence, formulation and compatible solvent from the specification. 2. Allow a cold sealed powder vial to reach room temperature before opening to reduce condensation. 3. Use clean/aseptic handling suitable for the experiment and compatible containers. 4. Prepare to the calculated final volume using a measured quantity basis. 5. Mix as specified, avoiding unnecessary foaming or transfer loss. 6. Compare appearance and solubility with the material’s specification; investigate unexpected particles or incomplete dissolution.
Foaming is not analytical proof of denaturation. Short peptides should not all be described as mechanically fragile proteins. A clear solution also does not prove identity, sterility or retained peptide content.
Storage and working life
Unopened water: follow the actual label. The cited official Bacteriostatic Water for Injection label specifies controlled room temperature, 20–25°C. Do not replace its instructions with a universal refrigeration rule.
After vial puncture: CDC’s clinical multidose-vial convention is discard after 28 days unless the manufacturer specifies another period, without exceeding the manufacturer’s original expiry. This is an infection-control convention for labelled multidose products, not a measured chemical-stability period for every peptide. It does not by itself require 2–8°C storage.
Reconstituted peptide: use validated conditions for the exact formulation, concentration and container, with an appropriate microbial-control procedure. Freezing/thawing effects and retained activity require material-specific evidence. A lot COA is useful only if it actually includes the relevant stability test; purity at one time point is not a shelf-life study. See the storage guide.
Conclusion
Choose the solvent by compatibility with the material and assay, then calculate concentration from verified target amount and final volume. Preservative concentration, microbial handling and chemical stability are separate checks. A clinical vial-discard convention cannot supply missing stability evidence for a laboratory peptide stock.
Research source
Source Bacteriostatic Water for your research
Compare available sizes and check the matching batch certificate before ordering.
View productFrequently Asked Questions
What is the difference between bacteriostatic water and sterile water?
Bacteriostatic water includes a stated preservative concentration, commonly 0.9% benzyl alcohol; unpreserved sterile water does not. The additive can affect an assay and does not sterilize contamination. For laboratory stocks, choose by compatibility and the handling protocol rather than a universal multi-entry rule.
How long does bacteriostatic water last after opening?
Follow the actual product label. CDC’s clinical multidose-vial convention is 28 days after puncture unless the manufacturer gives another period, and never beyond the manufacturer’s original expiry. That is not a universal refrigerated peptide-stability result. The cited water label specifies 20–25°C storage; a peptide solution needs its own validated conditions.
How much bacteriostatic water should be added to a vial?
Use the protocol’s concentration and the verified target-peptide amount, preparing to a defined final volume. Ten verified milligrams in 2.00 mL final solution gives 5 mg/mL. Nominal vial mass and HPLC peak-area purity alone do not establish the target amount.
Can bacteriostatic water be used with every peptide?
No. Solubility, peptide stability and assay sensitivity to benzyl alcohol must be checked for the exact formulation. A validated buffer or co-solvent may be required, and substituting solvents changes the experiment.
Why should the vial not be shaken after adding solvent?
Follow the material’s mixing specification. Avoiding unnecessary foam can reduce handling loss, but foam itself does not prove peptide denaturation. Confirm solubility and integrity with appropriate checks rather than a visual damage diagnosis.
Is bacteriostatic water a research compound?
It is a solvent/diluent, but products labelled Bacteriostatic Water for Injection also have regulated clinical labels. A laboratory catalogue description does not remove product-specific requirements or authorize human use. Match the actual product and use to its documentation.
Scientific References
- DailyMed. Bacteriostatic Water for Injection manufacturer label - Primary source
- CDC. Clinical multidose-vial handling and limits of preservatives - Primary source
- Merck/Sigma-Aldrich. Peptide handling, solubility and net content - Primary source
